Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Abstract Background JAK inhibitors are a relatively new class of medications that may be useful in the treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA). The objective of this study was to determine the efficacy of several JAK inhibitors in treating psoriasis and PsA and examin...

Full description

Bibliographic Details
Main Authors: Samantha Sarabia, Brandan Ranjith, Sahil Koppikar, Don Thiwanka Wijeratne
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Rheumatology
Subjects:
Psoriatic arthritis
Psoriasis
JAK inhibitors
Tofacitinib
Upadacitinib
Online Access:https://doi.org/10.1186/s41927-022-00287-7

Similar Items

Similar Items